ANTIRADICAL THERAPEUTICS LLC — Department of Defense SBIR Phase II: DHA17-011
ANTIRADICAL THERAPEUTICS LLC — SBIR Phase II award from Department of Defense.
- Amount
- $999,817
- Agency
- Department of Defense · Defense Health Program
- Program / Phase
- SBIR · Phase II
- Topic
- DHA17-011
- Solicitation
- 17.1
- NAICS
- —
- Place of performance
- SD
- Period
- 2018-12-03 → 2021-05-02
Description
An ideal therapeutic for traumatic brain injury (TBI) accompanied by hemorrhagic shock (HS) should serve both as a resuscitation fluid to restore perfusion pressure while directly protecting the brain from secondary injury. Previous work in mice demonstra